NCT06044597View on ClinicalTrials.gov

Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV).

NANot yet recruitingINTERVENTIONAL

Enrollment

722

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

October 30, 2026

Conditions

Heart Failure

Interventions

DEVICE

SyncAV function on

CRT-D with SyncAV plus activated

All Listed Sponsors

lead

Antonio Rapacciuolo

OTHER

NCT06044597 - Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV). | Biotech Hunter | Biotech Hunter